Search alternatives:
small decrease » small increased (Expand Search)
Showing 321 - 340 results of 2,607 for search '(( ((aromatic decrease) OR (dramatic decrease)) ) OR ( ((somatic decrease) OR (small decrease)) ))', query time: 0.30s Refine Results
  1. 321

    Faster-RCNN. by Junyan Wang (4738518)

    Published 2025
    Subjects:
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328

    Proportion of large and small EEFs over time in the different culture conditions and for each biological replicate. by Erica M. Pasini (3146643)

    Published 2025
    “…This decline continues and on day 11 the culture appears enriched in small EEF (hypnozoites). Drug-treated <i>P. cynomolgi</i> biological replicates on day 9 show a continued decrease in EEFs. …”
  9. 329

    Supplementary Material for: Supportive care for common conditions in small vulnerable newborns and term infants: the evidence by Jiang L. (4145290)

    Published 2025
    “…Introduction Small vulnerable newborns (SVN) are at an increased risk of early death and other morbidities. …”
  10. 330

    Table 4_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.xlsx by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  11. 331

    Table 2_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.xlsx by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  12. 332

    Table 1_Repurposing of the small-molecule adrenoreceptor-inhibitor carvedilol for treatment of the fibrotic lung.xlsx by Maria Jordan (10265489)

    Published 2025
    “…</p>Methods<p>In silico modeling of dysregulated pathways in IPF and screening for putative interfering small molecules identified carvedilol as a promising anti-fibrotic agent. …”
  13. 333

    Table 1_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.docx by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  14. 334

    Table 3_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.xlsx by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  15. 335

    Image 3_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.tif by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  16. 336

    Image 1_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.tif by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  17. 337

    Image 2_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.tif by Thibaud Dauphin (21196820)

    Published 2025
    “…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
  18. 338
  19. 339
  20. 340